HEADER TRANSFERASE 31-MAY-12 4AW5 TITLE COMPLEX OF THE EPHB4 KINASE DOMAIN WITH AN OXINDOLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPHRIN TYPE-B RECEPTOR 4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 605-890; COMPND 5 SYNONYM: EPHRIN B4, HEPATOMA TRANSMEMBRANE KINASE, TYROSINE-PROTEIN COMPND 6 KINASE TYRO11; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.H.TILL,T.J.STOUT REVDAT 1 01-AUG-12 4AW5 0 JRNL AUTH M.H.KIM,A.L.TSUHAKO,E.W.CO,D.T.AFTAB,F.BENTZIEN,J.CHEN, JRNL AUTH 2 W.CHENG,S.ENGST,L.GOON,R.R.KLEIN,D.T.LE,M.MAC,J.J.PARKS, JRNL AUTH 3 F.QIAN,M.RODRIQUEZ,T.J.STOUT,J.H.TILL,K.A.WON,X.WU, JRNL AUTH 4 F.MICHAEL YAKES,P.YU,W.ZHANG,Y.ZHAO,P.LAMB,J.M.NUSS,W.XU JRNL TITL THE DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF POTENT JRNL TITL 2 RECEPTOR TYROSINE KINASE INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 4979 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22765894 JRNL DOI 10.1016/J.BMCL.2012.06.029 REMARK 2 REMARK 2 RESOLUTION. 2.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 99.93 REMARK 3 NUMBER OF REFLECTIONS : 12054 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.19439 REMARK 3 R VALUE (WORKING SET) : 0.19015 REMARK 3 FREE R VALUE : 0.27894 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.1 REMARK 3 FREE R VALUE TEST SET COUNT : 642 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.330 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.391 REMARK 3 REFLECTION IN BIN (WORKING SET) : 866 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.261 REMARK 3 BIN FREE R VALUE SET COUNT : 57 REMARK 3 BIN FREE R VALUE : 0.317 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2063 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 91 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.445 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.05 REMARK 3 B22 (A**2) : -3.27 REMARK 3 B33 (A**2) : 1.83 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 3.63 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.369 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.282 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.208 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.957 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2149 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1975 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2911 ; 1.938 ; 1.973 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4582 ; 1.452 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 261 ; 6.898 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 313 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2384 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 455 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 443 ; 0.226 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2111 ; 0.241 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 1105 ; 0.107 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 64 ; 0.207 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 7 ; 0.119 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 28 ; 0.272 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.113 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1302 ; 0.921 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2104 ; 1.694 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 847 ; 1.994 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 806 ; 3.498 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 4AW5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-JUN-12. REMARK 100 THE PDBE ID CODE IS EBI-52713. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-OCT-02 REMARK 200 TEMPERATURE (KELVIN) : 93.2 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 32-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00036 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12716 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.33 REMARK 200 RESOLUTION RANGE LOW (A) : 54.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.7 REMARK 200 R MERGE (I) : 0.12 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.40 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.33 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.46 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.6 REMARK 200 R MERGE FOR SHELL (I) : 0.46 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.80 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: IN-HOUSE APO STRUCTURE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.8 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 26.98900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 76 REMARK 465 TRP A 77 REMARK 465 GLY A 78 REMARK 465 SER A 79 REMARK 465 MET A 80 REMARK 465 GLU A 81 REMARK 465 PHE A 82 REMARK 465 LEU A 237 REMARK 465 SER A 238 REMARK 465 ARG A 239 REMARK 465 PHE A 240 REMARK 465 LEU A 241 REMARK 465 GLU A 242 REMARK 465 GLU A 243 REMARK 465 ASN A 244 REMARK 465 SER A 245 REMARK 465 SER A 246 REMARK 465 ASP A 247 REMARK 465 PRO A 248 REMARK 465 THR A 249 REMARK 465 TYR A 250 REMARK 465 THR A 251 REMARK 465 SER A 252 REMARK 465 SER A 253 REMARK 465 LEU A 254 REMARK 465 GLY A 255 REMARK 465 GLY A 256 REMARK 465 LYS A 257 REMARK 465 ARG A 365 REMARK 465 GLU A 366 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 126 CG CD CE NZ REMARK 470 ILE A 258 CG1 CG2 CD1 REMARK 470 LYS A 335 CG CD CE NZ REMARK 470 LYS A 361 CG CD CE NZ REMARK 470 VAL A 363 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 216 CB - CG - OD2 ANGL. DEV. = 7.0 DEGREES REMARK 500 ASP A 234 CB - CG - OD2 ANGL. DEV. = 7.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 95 125.10 174.34 REMARK 500 SER A 162 -162.94 -129.59 REMARK 500 ARG A 215 -11.80 67.50 REMARK 500 SER A 233 -155.32 -115.60 REMARK 500 ASP A 234 73.81 63.85 REMARK 500 TRP A 298 -93.23 4.82 REMARK 500 ASN A 356 60.87 -119.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 30K A1365 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BBA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE AND THERMODYNAMIC CHARACTERIZATION OF REMARK 900 THEEPHB4 RECEPTOR IN COMPLEX WITH AN EPHRIN-B2 REMARK 900 ANTAGONISTPEPTIDE REVEALS THE DETERMINANTS FOR RECEPTOR REMARK 900 SPECIFICITY REMARK 900 RELATED ID: 2VWU RELATED DB: PDB REMARK 900 EPHB4 KINASE DOMAIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 2VWV RELATED DB: PDB REMARK 900 EPHB4 KINASE DOMAIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 2VWW RELATED DB: PDB REMARK 900 EPHB4 KINASE DOMAIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 2VWX RELATED DB: PDB REMARK 900 EPHB4 KINASE DOMAIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 2VWY RELATED DB: PDB REMARK 900 EPHB4 KINASE DOMAIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 2VWZ RELATED DB: PDB REMARK 900 EPHB4 KINASE DOMAIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 2VX0 RELATED DB: PDB REMARK 900 EPHB4 KINASE DOMAIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 2VX1 RELATED DB: PDB REMARK 900 EPHB4 KINASE DOMAIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 2X9F RELATED DB: PDB REMARK 900 EPHB4 KINASE DOMAIN INHIBITOR COMPLEX REMARK 900 RELATED ID: 2XVD RELATED DB: PDB REMARK 900 EPHB4 KINASE DOMAIN INHIBITOR COMPLEX DBREF 4AW5 A 81 366 UNP P54760 EPHB4_HUMAN 605 890 SEQADV 4AW5 PRO A 76 UNP P54760 EXPRESSION TAG SEQADV 4AW5 TRP A 77 UNP P54760 EXPRESSION TAG SEQADV 4AW5 GLY A 78 UNP P54760 EXPRESSION TAG SEQADV 4AW5 SER A 79 UNP P54760 EXPRESSION TAG SEQADV 4AW5 MET A 80 UNP P54760 EXPRESSION TAG SEQRES 1 A 291 PRO TRP GLY SER MET GLU PHE ALA LYS GLU ILE ASP VAL SEQRES 2 A 291 SER TYR VAL LYS ILE GLU GLU VAL ILE GLY ALA GLY GLU SEQRES 3 A 291 PHE GLY GLU VAL CYS ARG GLY ARG LEU LYS ALA PRO GLY SEQRES 4 A 291 LYS LYS GLU SER CYS VAL ALA ILE LYS THR LEU LYS GLY SEQRES 5 A 291 GLY TYR THR GLU ARG GLN ARG ARG GLU PHE LEU SER GLU SEQRES 6 A 291 ALA SER ILE MET GLY GLN PHE GLU HIS PRO ASN ILE ILE SEQRES 7 A 291 ARG LEU GLU GLY VAL VAL THR ASN SER MET PRO VAL MET SEQRES 8 A 291 ILE LEU THR GLU PHE MET GLU ASN GLY ALA LEU ASP SER SEQRES 9 A 291 PHE LEU ARG LEU ASN ASP GLY GLN PHE THR VAL ILE GLN SEQRES 10 A 291 LEU VAL GLY MET LEU ARG GLY ILE ALA SER GLY MET ARG SEQRES 11 A 291 TYR LEU ALA GLU MET SER TYR VAL HIS ARG ASP LEU ALA SEQRES 12 A 291 ALA ARG ASN ILE LEU VAL ASN SER ASN LEU VAL CYS LYS SEQRES 13 A 291 VAL SER ASP PHE GLY LEU SER ARG PHE LEU GLU GLU ASN SEQRES 14 A 291 SER SER ASP PRO THR TYR THR SER SER LEU GLY GLY LYS SEQRES 15 A 291 ILE PRO ILE ARG TRP THR ALA PRO GLU ALA ILE ALA PHE SEQRES 16 A 291 ARG LYS PHE THR SER ALA SER ASP ALA TRP SER TYR GLY SEQRES 17 A 291 ILE VAL MET TRP GLU VAL MET SER PHE GLY GLU ARG PRO SEQRES 18 A 291 TYR TRP ASP MET SER ASN GLN ASP VAL ILE ASN ALA ILE SEQRES 19 A 291 GLU GLN ASP TYR ARG LEU PRO PRO PRO PRO ASP CYS PRO SEQRES 20 A 291 THR SER LEU HIS GLN LEU MET LEU ASP CYS TRP GLN LYS SEQRES 21 A 291 ASP ARG ASN ALA ARG PRO ARG PHE PRO GLN VAL VAL SER SEQRES 22 A 291 ALA LEU ASP LYS MET ILE ARG ASN PRO ALA SER LEU LYS SEQRES 23 A 291 ILE VAL ALA ARG GLU HET 30K A1365 37 HETNAM 30K (3Z)-5-[(1-ETHYLPIPERIDIN-4-YL)AMINO]-3-[(5- HETNAM 2 30K METHOXY-1H-BENZIMIDAZOL-2-YL)(PHENYL) HETNAM 3 30K METHYLIDENE]-1,3-DIHYDRO-2H-INDOL-2-ONE FORMUL 2 30K C30 H31 N5 O2 FORMUL 3 HOH *91(H2 O) HELIX 1 1 ASP A 87 SER A 89 5 3 HELIX 2 2 THR A 130 LEU A 138 1 9 HELIX 3 3 LEU A 138 GLN A 146 1 9 HELIX 4 4 ALA A 176 ASN A 184 1 9 HELIX 5 5 THR A 189 MET A 210 1 22 HELIX 6 6 ALA A 218 ARG A 220 5 3 HELIX 7 7 PRO A 259 THR A 263 5 5 HELIX 8 8 ALA A 264 ARG A 271 1 8 HELIX 9 9 THR A 274 SER A 291 1 18 HELIX 10 10 SER A 301 GLN A 311 1 11 HELIX 11 11 PRO A 322 TRP A 333 1 12 HELIX 12 12 ASP A 336 ARG A 340 5 5 HELIX 13 13 ARG A 342 ASN A 356 1 15 HELIX 14 14 PRO A 357 LYS A 361 5 5 SHEET 1 AA 5 VAL A 91 GLY A 100 0 SHEET 2 AA 5 GLY A 103 LEU A 110 -1 O GLY A 103 N GLY A 100 SHEET 3 AA 5 SER A 118 LEU A 125 -1 O SER A 118 N LEU A 110 SHEET 4 AA 5 VAL A 165 GLU A 170 -1 O VAL A 165 N LEU A 125 SHEET 5 AA 5 LEU A 155 VAL A 159 -1 N GLU A 156 O LEU A 168 SHEET 1 AB 2 ILE A 222 VAL A 224 0 SHEET 2 AB 2 CYS A 230 VAL A 232 -1 O LYS A 231 N LEU A 223 CISPEP 1 MET A 163 PRO A 164 0 -0.44 SITE 1 AC1 15 ILE A 97 ALA A 121 LYS A 123 ILE A 153 SITE 2 AC1 15 THR A 169 GLU A 170 PHE A 171 MET A 172 SITE 3 AC1 15 GLU A 173 GLY A 175 ARG A 220 ASN A 221 SITE 4 AC1 15 LEU A 223 ASP A 234 HOH A2005 CRYST1 46.657 53.978 63.242 90.00 111.06 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021433 0.000000 0.008253 0.00000 SCALE2 0.000000 0.018526 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016944 0.00000